glutamic acid and kavain

glutamic acid has been researched along with kavain in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beile, A; Gleitz, J; Peters, T1
Ameri, A; Beile, A; Friese, J; Gleitz, J; Peters, T1
Boonen, G; Ferger, B; Häberlein, H; Kuschinsky, K1
Ferger, B; Schmidt, N1

Other Studies

4 other study(ies) available for glutamic acid and kavain

ArticleYear
(+/-)-kavain inhibits the veratridine- and KCl-induced increase in intracellular Ca2+ and glutamate-release of rat cerebrocortical synaptosomes.
    Neuropharmacology, 1996, Volume: 35, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Calcium; Cerebral Cortex; Fura-2; Glutamic Acid; Ionophores; Male; Monensin; Potassium Chloride; Pyrones; Rats; Rats, Wistar; Synaptosomes; Veratridine

1996
Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites.
    European journal of pharmacology, 1996, Nov-07, Volume: 315, Issue:1

    Topics: 4-Aminopyridine; Animals; Anticonvulsants; Batrachotoxins; Calcium; Cerebral Cortex; Dose-Response Relationship, Drug; Glutamic Acid; Male; Pyrones; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Synaptosomes

1996
In vivo microdialysis study of (+/-)-kavain on veratridine-induced glutamate release.
    European journal of pharmacology, 1998, Apr-24, Volume: 347, Issue:2-3

    Topics: Animals; Anticonvulsants; Brain; Drug Interactions; Glutamic Acid; Male; Microdialysis; Pyrones; Rats; Rats, Wistar; Tetrodotoxin; Veratridine

1998
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
    Synapse (New York, N.Y.), 2001, Volume: 40, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Brain; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Degeneration; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Pyrones; Substantia Nigra; Tyrosine 3-Monooxygenase

2001